Socio-demographic |
Sex |
8 female, 7 male |
Age (Years) |
56.6 ± 2.4 |
BMI |
34.0 ± 1.3 |
Anemia |
|
Hematocrit (%) |
35.49 ± 0.61 |
HCT CALC (HGBX3) |
34.94 ± 0.62 |
Hemoglobin (g/dL) |
11.68 ± 0.20 |
Iron management |
Iron saturation (%) |
34.47 ± 3.51 |
Iron |
79.57 ± 7.78 |
TIBC (µg/dL) |
233.18 ± 9.05 |
UIBC (µg/dL) |
149.67 ± 12.46 |
Osteodystrophy |
Calcium (mg/dL) |
9.11 ± 0.33 |
Phosphorus (mg/dL) |
5.75 ± 0.48 |
Cal×Phos product |
51.56 ± 4.48 |
Alkaline Phosphatase (mg/dL) |
111.13 ± 20.40 |
Calcium corrected |
9.35 ± 0.32 |
Cal×Phos product corrected |
53.11 ± 4.68 |
Nutrition and Lipids |
|
Potassium (mg/dL) |
4.49 ± 0.13 |
Albumin (mg/dL) |
3.70 ± 0.10 |
Adequacy of dialysis and renal function |
|
Creatinine (µmoles/L) |
7.44 ± 0.81 |
Blood Urea Nitrogen |
54.73 ± 3.04 |
Kt/V (K=dialyzer clearance of urea, t=dialysis time and V=volume of distribution of urea in the body) |
2.47 ± 0.13 |
Residual renal function (mL/Min) |
6.68 ± 1.36 |
Duration of dialysis |
9 patients (>6 months)
6 patients (<6 Months) |
Dialysis regimen |
2 patients were on CAPD
13 Patients were on CCPD |